当前位置: X-MOL 学术Mol. Neurodegener. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma
Molecular Neurodegeneration ( IF 15.1 ) Pub Date : 2019-01-22 , DOI: 10.1186/s13024-018-0303-3
Pete A. Williams , Catherine E. Braine , Krishnakumar Kizhatil , Nicole E. Foxworth , Nicholas G. Tolman , Jeffrey M. Harder , Rebecca A. Scott , Gregory L. Sousa , Alyssa Panitch , Gareth R. Howell , Simon W. M. John

Glaucoma is characterized by the progressive dysfunction and loss of retinal ganglion cells. Recent work in animal models suggests that a critical neuroinflammatory event damages retinal ganglion cell axons in the optic nerve head during ocular hypertensive injury. We previously demonstrated that monocyte-like cells enter the optic nerve head in an ocular hypertensive mouse model of glaucoma (DBA/2 J), but their roles, if any, in mediating axon damage remain unclear. To understand the function of these infiltrating monocyte-like cells, we used RNA-sequencing to profile their transcriptomes. Based on their pro-inflammatory molecular signatures, we hypothesized and confirmed that monocyte-platelet interactions occur in glaucomatous tissue. Furthermore, to test monocyte function we used two approaches to inhibit their entry into the optic nerve head: (1) treatment with DS-SILY, a peptidoglycan that acts as a barrier to platelet adhesion to the vessel wall and to monocytes, and (2) genetic targeting of Itgam (CD11b, an immune cell receptor that enables immune cell extravasation). Monocyte specific RNA-sequencing identified novel neuroinflammatory pathways early in glaucoma pathogenesis. Targeting these processes pharmacologically (DS-SILY) or genetically (Itgam / CD11b knockout) reduced monocyte entry and provided neuroprotection in DBA/2 J eyes. These data demonstrate a key role of monocyte-like cell extravasation in glaucoma and demonstrate that modulating neuroinflammatory processes can significantly lessen optic nerve injury.

中文翻译:

抑制单核细胞样细胞外渗可预防DBA / 2J青光眼的神经退行性变

青光眼的特征在于进行性功能障碍和视网膜神经节细胞丧失。在动物模型中的最新工作表明,在眼部高压性损伤期间,严重的神经炎症事件会损害视神经头部的视网膜神经节细胞轴突。我们以前曾证明过,在青光眼的高眼压小鼠模型(DBA / 2 J)中,单核细胞样细胞会进入视神经头部,但是它们在介导轴突损伤中的作用(如果有的话)仍然不清楚。为了了解这些浸润的单核细胞样细胞的功能,我们使用了RNA测序技术来分析其转录组。基于它们的促炎分子特征,我们假设并确认了青光眼组织中发生了单核细胞-血小板相互作用。此外,为了测试单核细胞功能,我们使用了两种方法来抑制单核细胞进入视神经头:(1)使用DS-SILY(一种肽聚糖,可作为血小板粘附到血管壁和单核细胞的屏障)进行处理,以及(2)Itgam的遗传靶向(CD11b,一种能够使免疫细胞外渗的免疫细胞受体)。单核细胞特异的RNA测序在青光眼发病机理的早期确定了新的神经炎性途径。药理学(DS-SILY)或遗传学(Itgam / CD11b敲除)靶向这些过程可减少单核细胞进入并为DBA / 2 J眼睛提供神经保护。这些数据证明了单核细胞样细胞外渗在青光眼中的关键作用,并证明调节神经炎症过程可以显着减轻视神经损伤。使免疫细胞外渗的免疫细胞受体)。单核细胞特异的RNA测序在青光眼发病机理的早期确定了新的神经炎性途径。药理学(DS-SILY)或遗传学(Itgam / CD11b敲除)靶向这些过程可减少单核细胞进入并在DBA / 2 J眼睛中提供神经保护作用。这些数据证明了单核细胞样细胞外渗在青光眼中的关键作用,并证明调节神经炎症过程可以显着减轻视神经损伤。使免疫细胞外渗的免疫细胞受体)。单核细胞特异的RNA测序在青光眼发病机理的早期确定了新的神经炎性途径。药理学(DS-SILY)或遗传学(Itgam / CD11b敲除)靶向这些过程可减少单核细胞进入并为DBA / 2 J眼睛提供神经保护。这些数据证明了单核细胞样细胞外渗在青光眼中的关键作用,并证明调节神经炎症过程可以显着减轻视神经损伤。
更新日期:2019-01-22
down
wechat
bug